Curis Inc. (NASDAQ: CRIS) is not exactly a household name, even when it comes to the land of biotech investors. The company has come under focus today after announcing that ... Read Full Story »
Today's version of the BioHealth Business Daily is a very unusual lot of movers. Some moves are merely in sympathy and some are on news. We also have a re-review ... Read Full Story »
There are many stocks on the move this morning in the top day trader alerts and top active trader alerts. BP plc (NYSE: BP), Curis Inc. (NASDAQ: CRIS), FedEx Corporation ... Read Full Story »
This weekend will be a potentially important oncology and cancer news weekend for drug and biotech stocks. The American Association for Cancer Research Meeting will actually have a 100th annual ... Read Full Story »
Curis Inc. (NASDAQ: CRIS) shares down 18% after development partner Wyeth terminated their contract that focused on cancer treatment developments. Shares are down $0.29 to $1.14. The 52 week range ... Read Full Story »